Xiaoyan Michelle Zhang - Nov 22, 2021 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Chief Scientific Officer
Signature
/s/ Douglas R. Carlson, as Attorney-in-Fact for Xiaoyan Michelle Zhang
Stock symbol
IKNA
Transactions as of
Nov 22, 2021
Transactions value $
$0
Form type
4
Date filed
11/23/2021, 08:01 PM
Next filing
Dec 14, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKNA Stock Option (Right to Buy) Award $0 +177K $0.00 177K Nov 22, 2021 Common Stock 177K $13.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest and become exercisable on November 22, 2022, with the remainder vesting in 36 equal monthly installments thereafter.